Skip to content

Effect of radial extracorporeal shock wave therapy and acupoint-based transcutaneous electrical nerve stimulation combined with usual physiotherapy treatment in post-stroke

Effect of radial extracorporeal shock wave therapy and acupoint-based transcutaneous electrical nerve stimulation combined with usual physiotherapy treatment in post-stroke impairment: a randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087383
Enrollment
120
Registered
2025-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I639- Cerebral infarction, unspecified

Interventions

Intervention1: Experimental group 1: rESWT+UPT: The patient will lie with the affected limbs, may or/ may not rest on a pillow. Patient will receive ESWT at 5 Hz, 1500 shots per muscle, with the energ

Sponsors

Kazi Md Azman Hossain
Lead Sponsor
Jashore University of Science and Technology JUST
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients with ischemic stroke confirmed by CT or MRI, with the first onset of stroke, and onset of stroke for more than 1 month. The clinical symptoms include unilateral limb paralysis and motor dysfunction of the upper and lower limbs. Patients have spasticity for modified Ashworth scale (MAS) scores equal or more than 1. Able to walk independently for 10 meters without help. Both male and female patients aged between 40 and 70 years. Stable state, clear consciousness, and no hearing or comprehension disabilities to complete the questionnaires. Participate voluntarily and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Patients with serious internal diseases, tumors and other malignant diseases, infectious diseases, and mental illnesses. Contraindications for electrical stimulation and ESWT: such as with pacemakers or other implantable devices; history of epilepsy or/and seizures; history of head trauma or head and spinal cord surgery; bleeding disorders; in pregnancy or lactation or planning to become pregnant in the next 6 months; injuries, swelling, or scarring at the skin of the stimulating sites; sensory disturbance or allergy to electrical stimulation. Have taken muscle relaxant drugs in the past month or have received botulinum toxin injections in a spastic limb within the past 6 months.

Design outcomes

Secondary

MeasureTime frame
Stroke-Specific Quality of Life, 10-Meter Walk TestTimepoint: At baseline, week-6 & week-18

Primary

MeasureTime frame
Spasticity: Modified Ashworth Scale (MAS), Modified Tardieu Scale (MTS); Motor Function: Fugl-Meyer Assessment (FMA - Upper limb and Lower limb)Timepoint: At baseline, week-6 and week-18

Countries

Bangladesh

Contacts

Public ContactJannatul Ferdous Rikti

Jashore University of Science and Technology (JUST), Jashore

azmanhossain51@gmail.com01660140833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026